Devices › Stimulator, spinal-cord, totally implanted for pain relief
Device brand name · Scs ipg
Proclaim 7 Elite Implantable Pulse Generator: medical device reports filed with FDA
5,836 reports name it, 2019–2026. Manufacturer given most often on reports: Abbott Medical. Product code LGW.
- 5,836
- device reports naming the brand
- 0% of all MAUDE reports · about 855 a year
- 333
- reports, 12 months to August 2026
- 513 in the 12 months before
- 12.6%
- classified as malfunction
- 27.3% across the product code
- 0.1%
- classified as death, as reported
- 4 reports · not verified by FDA
5,836 medical device reports received by FDA name the brand "Proclaim 7 Elite Implantable Pulse Generator" (scs ipg); the manufacturer given most often on reports is Abbott Medical; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
333 reports arrived in the 12 months to August 2026, down 35% from 513 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (87.4%), malfunction (12.6%) and death (0.1%); across all stimulator, spinal-cord, totally implanted for pain relief reports (product code LGW) death is recorded in 0.5% and malfunction in 27.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are battery problem (24.8%), wireless communication problem (24.4%) and insufficient device problem information (14.5%). The patient problems coded most often are inadequate pain relief, failure of implant and implant pain. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 378,355 reports carrying product code LGW. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Battery problema problem with the battery | 1,449 | 24.8% | 7.8% |
| Wireless communication problema wireless connection problem | 1,426 | 24.4% | 3.4% |
| Insufficient device problem information | 847 | 14.5% | 6.8% |
| Premature elective replacement indicator | 418 | 7.2% | 1% |
| Therapeutic or diagnostic output failure | 210 | 3.6% | 3.5% |
| Migrationthe device moved from where it was placed | 147 | 2.5% | 5.7% |
| High impedance | 64 | 1.1% | 9.7% |
| Premature discharge of battery | 56 | 1% | 1.1% |
| Impedance problem | 37 | 0.6% | 1.9% |
| Temperature problem | 30 | 0.5% | 1.5% |
| Inappropriate/inadequate shock/stimulation | 28 | 0.5% | 3.7% |
| Disconnection | 22 | 0.4% | 0.4% |
| Low impedance | 18 | 0.3% | 0.7% |
| Unexpected shutdown | 16 | 0.3% | 0.1% |
| Extracardiac stimulation | 10 | 0.2% | 0.2% |
| Device damaged by another device | 8 | 0.1% | 0% |
| No device output | 7 | 0.1% | 1.2% |
| Improper or incorrect procedure or method | 6 | 0.1% | 2.6% |
| Application program freezes or fails to launch | 5 | 0.1% | 0.2% |
| Delayed alarm | 2 | 0% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Inadequate pain relief | 3,244 | 55.6% |
| Failure of implant | 1,239 | 21.2% |
| Implant pain | 783 | 13.4% |
| Painpain, site not specified | 180 | 3.1% |
| Discomfortdiscomfort | 151 | 2.6% |
| Post operative wound infection | 71 | 1.2% |
| Burning sensationa burning feeling | 40 | 0.7% |
| Undesired nerve stimulation | 40 | 0.7% |
| Wound dehiscencea wound reopened | 23 | 0.4% |
| Pocket erosion | 20 | 0.3% |
| Erosion | 17 | 0.3% |
| Fluid discharge | 9 | 0.2% |
| Bacterial infectiona bacterial infection | 5 | 0.1% |
| Hypersensitivity/allergic reaction | 5 | 0.1% |
| Skin erosion | 4 | 0.1% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Proclaim 7 Elite Implantable Pulse Generator | Product code LGW | All MAUDE reports |
|---|---|---|---|
| Reports | 5,836 | 378,355 | 26,136,888 |
| Share of that pool | — | 1.5% | 0% |
| Classified as death, per 1,000 reports | 1 | 5 | 9 |
| Classified as injury | 87.4% | 72% | 36.2% |
| Classified as malfunction | 12.6% | 27.3% | 62.3% |
| Filed by the manufacturer | 100% | 99.5% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LGW
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Intellis | 42,032 | 4,743 | 0% |
| Octrode Lead Kit, 60cm Length | 47,037 | 5,133 | 0.1% |
| SureScan | 33,123 | 490 | 0% |
| Precision? | 26,020 | 446 | 0.4% |
| Proclaim 5 Elite Implantable Pulse Generator | 20,816 | 2,057 | 0.1% |
| Precision Spectra ? | 16,858 | 971 | 0.5% |
| Restore Ultra | 13,500 | 39 | 0.1% |
| Eon Mini IPG, 16-Channel Rechargeable | 14,176 | 111 | 0.2% |
| Restore Sensor | 10,934 | 40 | 0.1% |
| Spectra WaveWriter? | 7,766 | 1,093 | 0.4% |
| Penta 3mm Lead, 60 cm | 9,617 | 839 | 0.3% |
| Senza | 6,423 | 718 | 15.1% |
| Eon Mini | 9,122 | 0 | 0.6% |
| WaveWriter Alpha? | 4,965 | 1,591 | 0.9% |
| Proclaim 5 Elite | 4,835 | 0 | 0.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Proclaim 7 Elite Implantable Pulse Generator reports
How many FDA reports name Proclaim 7 Elite Implantable Pulse Generator?
5,836 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 333 in the latest 12 months.
What kinds of events are reported?
injury (87.4%), malfunction (12.6%) and death (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
battery problem (24.8%), wireless communication problem (24.4%), insufficient device problem information (14.5%), premature elective replacement indicator (7.2%) and therapeutic or diagnostic output failure (3.6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Proclaim 7 Elite Implantable Pulse Generator was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.